Individual Study / SIGNATURE

Signature Biobank - Banks of biological, psychosocial and clinical data on people suffering from mental health problems

Signature Biobank - Banks of biological, psychosocial and clinical data on people suffering from mental health problems

SIGNATURE logo
Networks -
Datasets -
Variables -
Start Year
2012
End Year
2021
Supplementary Information
**Papers of Interest** L. Dion-Albert, A. Cadoret, E. Doney, et al. Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue. Nat. Com. 13, 64 (2022)

V. Laliberté, C.-É. Giguère, S. Potvin, A. Lesage. Berkson's bias in biobank sampling in a specialized mental health care setting: a comparative cross-sectional study. BMJ Open 10(7):35088 July 2020

S. Potvin, L. Mahrouche, R. Assaf, et al. Furtos, R.Godbout on behalf of the Signature Consortium. Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting. Front. Psychiatry, 30 June 2020

T. Lecomte, C.-É. Giguère, B. Cloutier, S. et al.Comorbidity Profiles of Psychotic Patients in Emergency Psychiatry. Journal of Dual Diagnosis, 2020 Jan Vol.16 (issue2) 260:270

M.-F. Marin, S. Geoffrion, C.-É. Giguère, et al.The Moderating Role of Age in the Relationship Between Early Life Adversity and Hair Cortisol Concentrations in Adults Admitted to a Psychiatric Emergency Service. Biological Psychiatry, 2019 May 85(10): S146-S147

Visit SIGNATURE

Members

Download
Investigators Contacts
  • Dr. Stéphane Guay
    Centre de recherche de l'Institut universitaire en santé mentale de Montréal (CR-IUSMM)
  • Dr. Robert-Paul Juster
    Universite de Montreal
  • Dr. Cécile Le Page
    Centre de recherche de l’Institut universitaire en santé mentale de Montréal (CR-IUSMM)

Design

Study design
Cohort
Follow Up
**Mental Health Patients** Participants are followed-up at 4 different points in their clinical journey, ie. when entering the emergency room, during treatment in an inpatient unit and during recovery in an outpatient clinic. **Controls** After first recruitment, a sub-group of participants are followed up for a second time within a month and at between 2016 and 2021.
Supplementary Information
Study designs: Cohort and case-control

Marker Paper

S.J. Lupien, M. Sasseville, N. Francois, et al. Lesage and Signature Consortium. Stress 20, 2-18 (2017)

PUBMED 28124571

Recruitment

Recruitment Target
  • Individuals

Number of Participants

Number of Participants
2,322
Number of Participants with Biological Samples
2,135
Supplementary Information
* Mental health patients: 2173 participants * Mental health patients with biosamples: 1986 participants * Controls: 149 partipants * Controls with biosamples: 149 participants

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other

Availability of access information

On the study website : https://criusmm.ciusss-estmtl.gouv.qc.ca/fr/pro...

By contacting the study representative

Sector of research

Possible Access to Data Possible Access to Biosamples
Investigators from the public sector
Investigators from the private sector
Investigators from not-for-profit organization

Researchers from the private sector needs to be a collaborator of one of the Signature consortium members.

Transfer

Possible Access to Data Possible Access to Biosamples
Can leave the study facility
Can leave the country

Cost

Possible Access to Data Fixed Cost
Possible Access to Biosamples Fixed Cost

Biological sample prices range from $20 to $40 per sample.

Cost reduction for co-analyses

Possible Access to Data
Possible Access to Biosamples

Members of the Alliance santé mentale au Québec benefit from a reduction.

Supplementary Information

To access the data, a duly completed request form, REB approval, a study protocol, and approval from the Signature Access Committee are required.

Timeline

Populations

Selection Criteria
Minimum age
18
Maximum age
81
Newborns
Twins
Countries
  • Canada
Territory
Montreal
Ethnic Origin
Health Status
  • Participants are patients who had a mental crisis.
Other Criteria
Participants admitted to one of two programs targeted by the project: the anxiety and mood disorder (AMD) program or the first psychotic episode (FPE) program are elligibale for the second (T2), third (T3) and fourth (T4) follow up. Pregnant women are excluded.

Recruitment

Sources of recruitment
  • Specific population
Specific Population
  • Clinic patients
Supplementary Information
Patients were recruited from the psychiatric emergency of the Hôpital Louis Lafontaine emergency room.

Number of Participants

Number of Participants
2,173
Number of Participants with Biological Samples
1,986
Supplementary Information about selection criteria
**Mental Health Patients T1** * 2,173 participants * 1,986 biological samples **Mental Health Patients T2** * 885 participants * 885 biological samples **Mental Health Patients T3** * 793 participants * 779 biological samples **Mental Health Patients T4** * 473 participants * 473 biological samples
Data Collection Events
# Name Description Start End
0 SIGNATURE - Mental Health Patients - T1 Sociodemographic information including gender and sex identity, spiritual beliefs, social functioning, childhood experiences, and family background was collected. Information about family ... 2012-11 2020-03
1 SIGNATURE - Mental Health Patients - T2 Sociodemographic information including gender and sex identity, spiritual beliefs, social functioning, childhood experiences, and family background was also collected. Information about family ... 2013-01 2020-03
2 SIGNATURE - Mental Health Patients - T3 Sociodemographic information including gender and sex identity, spiritual beliefs, social functioning, childhood experiences, and family background was also collected. Information about family ... 2013-01 2020-10
3 SIGNATURE - Mental Health Patients - T4 Sociodemographic information including gender and sex identity, spiritual beliefs, social functioning, childhood experiences, and family background was also collected. Information about family ... 2014-02 2021-03
Selection Criteria
Minimum age
18
Maximum age
81
Newborns
Twins
Countries
  • Canada
Territory
East part of the Montreal Island
Ethnic Origin
Health Status
Other Criteria
The control group was locally recruited to match age, sex and economic status of the patient cohort. Pregnant women are excluded.
Supplementary Information about selection criteria

Recruitment

Sources of recruitment
  • General population
General Population
  • Volunteer enrolment
Supplementary Information
Participants are voluntary patients recruited within the communities of the eastern part of the Montreal Island.

Number of Participants

Number of Participants
149
Number of Participants with Biological Samples
149
Supplementary Information about selection criteria
A sub-group of 30 had a second follow-up T2 (within 1 month after first recruitment).
Data Collection Events
# Name Description Start End
0 SIGNATURE - Controls - T1 Sociodemographic information including gender and sex identity, spiritual beliefs, social functioning, childhood experiences, and family background was also collected. Information about family ... 2016-09 2020-03
1 SIGNATURE - Controls - T2 Sociodemographic information including gender and sex identity, spiritual beliefs, social functioning, childhood experiences, and family background was also collected. Information about family ... 2016-09 2020-03
2 SIGNATURE - Controls - T4 Sociodemographic information including gender and sex identity, spiritual beliefs, social functioning, childhood experiences, and family background was also collected. Information about family ... 2016-02 2021-03

Classifications

Socio-demographic and economic characteristics
Lifestyle and behaviours
Birth, pregnancy and reproductive health history
Perception of health, quality of life, development and functional limitations
Diseases
Symptoms and signs
Medication and supplements
Non-pharmacological interventions
Health and community care services utilization
Death
Physical measures and assessments
Laboratory measures
Cognition, personality and psychological measures and assessments
Life events, life plans, beliefs and values
Preschool, school and work life
Social environment and relationships
Physical environment
Administrative information
Cognitive functioning
Personality
Psychological distress and emotions
Other psychological measures and assessments
Life events
Beliefs and values
Perception of health
Quality of life
Life course development
Functional limitations
Other perception of health, quality of life and functional limitation-related information
Tobacco
Alcohol
Drugs
Nutrition
Breastfeeding
Physical activity
Sleep
Sexual behaviours and orientation
Technological devices
Misbehaviour and criminality
Other and unspecified lifestyle information

Socio-demographic and economic characteristics

Age/birthdate
Sex/gender
Twin
Marital/partner status
Family and household structure
Education
Residence
Citizenship and immigrant status
Ethnicity, race and religion
Language
Labour force and retirement
Income, possessions, and benefits
Other socio-demographic and economic characteristics

Lifestyle and behaviours

Tobacco
Alcohol
Drugs
Sleep
Sexual behaviours and orientation
Misbehaviour and criminality
Other and unspecified lifestyle information

Birth, pregnancy and reproductive health history

Puberty, menstruation, menopause and andropause

Perception of health, quality of life, development and functional limitations

Functional limitations

Diseases

Neoplasms (C00-D48)
Endocrine, nutritional and metabolic diseases (E00-E90)
Mental and behavioural disorders (F00-F99)
Diseases of the nervous system (G00-G99)
Diseases of the circulatory system (I00-I99)
Diseases of the respiratory system (J00-J99)
Diseases of the digestive system (K00-K93)
Diseases of the musculoskeletal system and connective tissue (M00-M99)
Injury, poisoning and certain other consequences of external causes (S00-T98)
External causes of morbidity and mortality (V01-Y98)
Diseases without precise specification or falling into multiple categories

Symptoms and signs

Symptoms and signs involving the urinary system (R30-R39)

Medication and supplements

Medication and supplement intake

Health and community care services utilization

Hospitalizations

Physical measures and assessments

Anthropometry
Circulation and respiration

Laboratory measures

Biochemistry

Cognition, personality and psychological measures and assessments

Personality
Psychological distress and emotions

Life events, life plans, beliefs and values

Life events
Beliefs and values

Administrative information

Identifiers
Physical and cognitive measure and biosample-related information
Other administrative information

Personality

Brown-Goodwin Lifetime History of Aggression Scale
Urgency, Premeditation, Perseverance, Sensation Seeking, Positive Urgency, Impulsive Behavior Scale

Psychological distress and emotions

Patient Health Questionnaire
Psychosis Screening Questionnaire
Psychotic Symptom Rating Scales
Suicide Behaviour Questionnaire
Spielberger State-Trait Anxiety Inventory

Life events

Childhood Experiences of Violence Questionnaire

Functional limitations

World Health Organization Disability Assessment Schedule

Alcohol

Alcohol Use Disorders Identification Test

Drugs

Alcohol, Smoking and Substance Involvement Screening Test
Cannabis Abuse Screening Test
Drug abuse screening test

Sleep

Sleep Habits Questionnaire